Concordance Assessment of Pathology Results with Imaging Findings after Image-Guided Biopsy

• Published in: Journal of vascular and interventional radiology Vol. 33; no. 2; pp. 159 - 168.e1
• Main Authors: Camacho, Andrés, Chung, Andrew D., Rigiroli, Francesca, Sari, Mehmet Ali, Brook, Alexander, Siewert, Bettina, Ahmed, Muneeb, Brook, Olga Rachel
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2022
• Subjects: Humans; Image-Guided Biopsy - methods; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed - methods
• ISSN: 1051-0443; 1535-7732; 1535-7732
• DOI: 10.1016/j.jvir.2021.11.001

To assess the impact of radiology review for discordance between pathology results from computed tomography (CT)–guided biopsies versus imaging findings performed before a biopsy. In this retrospective review, which is compliant with the Health Insurance Portability and Accountability Act and approved by the institutional review board, 926 consecutive CT-guided biopsies performed between January 2015 and December 2017 were included. In total, 453 patients were presented in radiology review meetings (prospective group), and the results were classified as concordant or discordant. Results from the remaining 473 patients not presented at the radiology review meetings were retrospectively classified. Times to reintervention and to definitive diagnosis were obtained for discordant cases; of these, 49 (11%) of the 453 patients were in the prospective group and 55 (12%) of the 473 patients in the retrospective group. Pathology results from CT-guided biopsies were discordant with imaging in 11% (104/926) of the cases, with 57% (59/104) of these cases proving to be malignant. In discordant cases, reintervention with biopsy and surgery yielded a shorter time to definitive diagnosis (28 and 14 days, respectively) than an imaging follow-up (78 days) (P < .001). The median time to diagnosis was 41 days in the prospective group and 56 days in the retrospective group (P = .46). When radiologists evaluated the concordance between pathology and imaging findings and recommended a repeat biopsy for the discordant cases, more biopsies were performed (50% [11/22] vs 13% [4/31]; P = .005). Eleven percent of CT-guided biopsies yielded pathology results that were discordant with imaging findings, with 57% of these proving to be malignant on further workup.